Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4945198014 | Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4945199018 | Budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Is a | Budesonide and formoterol only product in pulmonary dose form | true | Inferred relationship | Some | ||
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has manufactured dose form | Powder for inhalation | true | Inferred relationship | Some | ||
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has unit of presentation | Actuation (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has precise active ingredient | Budesonide (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has basis of strength substance (attribute) | Budesonide (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has precise active ingredient | Formoterol fumarate dihydrate (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has basis of strength substance (attribute) | Formoterol fumarate dihydrate (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets